Digital health and biotech firms prepare to go public amid renewed investor interest
With the IPO window finally reopening, at least nine high-profile healthcare startups are reportedly preparing to go public in late 2025 or early 2026. According to banking insiders, this wave of IPOs signals a resurgence in investor confidence following a long pause in public listings.
Companies Eyeing the Public Market
Some of the top contenders include:
- Hinge Health – a musculoskeletal care platform
- Omada Health – a chronic disease management leader
- Lyra Health – mental health therapy and employer benefits platform
- Maven Clinic – women’s and family health services
- Virta Health – diabetes and metabolic care innovator
- Color Health – population genomics and personalized health
- Headway – therapist network platform
- SonderMind – mental health provider tech
- Cedar – healthcare payments startup
These companies span a variety of high-growth verticals such as digital therapeutics, FemTech, AI-based diagnostics, and value-based care—all of which are seeing strong investor demand.
Why Now?
- Improved market conditions: Stabilizing inflation and stronger stock performance are restoring IPO appetite.
- VC pressure: Many of these startups raised large late-stage rounds between 2020–2022 and are now under pressure to exit.
- Sector resilience: Digital health has shown staying power, especially in mental health, metabolic health, and virtual care delivery.
Outlook
Analysts expect the IPO wave to continue into 2026, especially if early listings perform well. Bankers predict healthcare startups may outperform traditional tech peers due to their recurring revenue, payer/provider partnerships, and regulatory tailwinds in value-based care.
Source Inspiration: Business Insider – These are the 9 healthcare startups next in line to go public, according to bankers and investors
